申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP0559893A1
公开(公告)日:1993-09-15
A novel xanthine derivative represented by general formula (I), which selectively antagonizes adenosine receptor, and a pharmacologically acceptable salt thereof. In formula (I) R¹ and R² may be the same or different from each other and each represents hydrogen, propyl, butyl or allyl; R³ represents hydrogen or lower alkyl; Y¹ and Y² may be the same or different from each other and each represents hydrogen or methyl; and Z represents (un)substituted phenyl, pyridyl, imidazolyl, furyl or thienyl.
一种由通式(I)代表的选择性拮抗腺苷受体的新型黄嘌呤衍生物及其药理上可接受的盐。在式 (I) 中,R¹ 和 R² 可以相同或不同,各自代表氢、丙基、丁基或烯丙基;R³ 代表氢或低级烷基;Y¹ 和 Y² 可以相同或不同,各自代表氢或甲基;Z 代表(未)取代的苯基、吡啶基、咪唑基、呋喃基或噻吩基。